[1]黄巧娟 周晓莉.冠状动脉慢血流现象的研究进展[J].心血管病学进展,2020,(2):163-166.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
 HUANG QiaojuanZHOU Xiaoli.Coronary Slow Flow Phenomenon[J].Advances in Cardiovascular Diseases,2020,(2):163-166.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.016]
点击复制

冠状动脉慢血流现象的研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年2期
页码:
163-166
栏目:
综述
出版日期:
2020-02-25

文章信息/Info

Title:
Coronary Slow Flow Phenomenon
作者:
黄巧娟 周晓莉
(重庆医科大学附属第一医院心血管内科,重庆 400016)
Author(s):
HUANG QiaojuanZHOU Xiaoli
(Department of Cardiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 40001 6,China)
关键词:
冠状动脉慢血流现象诊断标准发病机制治疗
Keywords:
Coronary slow flow phenomenon Diagnostic criteria Pathogenesis Treatment
DOI:
10.16806/j.cnki.issn.1004-3934.2020.02.016
摘要:
冠状动脉慢血流现象是一种病因不明的冠状动脉疾病,冠状动脉造影未见明显狭窄,但却存在血流灌注延迟的现象,其临床表现类似冠状动脉粥样硬化性心脏病。目前对冠状动脉慢血流现象发生的机制存在争议,治疗上也无明确指南。现主要对冠状动脉慢血流现象的诊断标准、发病机制和治疗方法做一综述。
Abstract:
Coronary slow flow phenomenon (CSFP) is a coronary artery disease of unknown etiology, which coronary angiography showed no obvious stenosis, but there was a delay in blood flow perfusion. Its clinical manifestations are similar to coronary atherosclerotic heart disease. At present, there is controversy about the mechanism of CSFP, and no clear treatment guide. This article reviews the diagnostic criteria, pathogenesis, and treatment of CSFP

参考文献/References:

[1] Wang X,Nie SP. The coronary slow flow phenomenon:characteristics,mechanisms and implications [J]. Cardiovasc Diagn Ther,2011,1(1):37-43.

[2] Beltrame J . Defining the coronary slow flow phenomenon[J]. Circ J,2012,76(4):818-820.

[3] Ganz W . The thrombolysis in myocardial infarction (TIMI) trial[J]. N Engl J Med ,1985,313(16):1018.

[4] Gibson CM,Cannon CP,Daley WL,et al. TIMI frame count:a quantitative method of assessing coronary artery flow[J]. Circulation ,1996,93(5):879-88.

[5] Yoon HJ,Jeong MH,Cho SH,et al. Endothelial dysfunction and increased carotid intima-media thickness in the patients with slow coronary flow[J]. J Korean Med Sci,2012:27(6):614-618.

[6] Pekdemir H,Cin VG,Cicek D,et al.Slow coronary may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS [J]. Acta Cardiol ,2004,59(2):127-133.

[7] Mangieri E,Macchiarelli G,Ciavolella M,et al. Slow coronary flow:clinical and histopathological features in patients with otherwise normal epicardial coronary arteries [J]. Catheter Cardiovasc Diagn ,1996,37(4):375-381.

[8] Beltrame JF,Limaye SB,Wuttke RD,et al. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon[J]. Am Heart J ,2003,146(1):84-90.

[9] Yurtda? M,?zcan IT,Seyis AS,et al. Plasma homocysteine is associated with ischemic ?ndings without organic stenosis in patients with slow coronary ?ow[J]. J Cardiol,2013,61(2):138-143.

[10] Zhao ZW,Ren YG,Liu J. Low serum adropin levels are associated with coronary slow flow phenomenon [J]. Acta Cardiol Sin ,2018,34:307-312.

相似文献/References:

[1]牛云霞 包针 杨玉春 何鹏义 木胡牙提.冠状动脉慢血流的危险因素及冠状动脉病变特点的研究[J].心血管病学进展,2022,(2):178.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.020]
 IU YunxiaBAO ZhenYANG YuchunHE PengyiMU Huyati.Risk Factors of Coronary Slow Flow and Characteristics of Coronary Artery Lesions[J].Advances in Cardiovascular Diseases,2022,(2):178.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.020]

更新日期/Last Update: 2020-04-14